Electronic Drug Delivery Systems Market 2020-2025 Size, Current Trends, Health Benefits, Key Players, Regional Overview and Business Growth Opportunity

1
Electronic Drug Delivery Systems Market

• Size 2018, By Product Type (Electronic Wearable
  Infusion Pumps, Electronic Autoinjectors,
  Electronic Injection Pens, Electronic Inhalers),
  Application (Cardiovascular Diseases, Multiple
  Sclerosis, Diabetes, Asthma COPD, Others),
  Region and Forecast 2019 to 2025

Single Use License US 4400
Request Sample
2
Global Electronic Drug Delivery Systems Market Is
Expected To Witness An Lucrative Growth With A
CAGR Of 7.9 Over The Forecast Period

• The global electronic drug delivery systems
  market is projected to reach an approximate value
  of USD 11.7 billion by 2025, growing at a CAGR of
  7.9. Increasing prevalence of diabetes and other
  chronic disorders such as cardiovascular
  diseases, COPD, asthma, and multiple sclerosis,
  rapidly growing geriatric population, favorable
  reimbursement scenario in developed regions are
  factors driving the electronic drug delivery
  systems market.
• Adroit Market Research report on global
  electronic drug delivery systems market gives a
  holistic view of the market from 2015 to 2025,
  which includes factors such as market drivers,
  restraints, opportunities and challenges. The
  market has been studied for historic years from
  2015 to 2017, with the base year of estimation as
  2018 and forecast from 2019 to 2025. The report
  covers the current status and future traits of
  the market at global as well as country level. In
  addition, the study also assesses the market
  based on Porter's five forces analysis and
  positions the key players based on their product
  portfolio, geographic footprint, strategic
  initiatives and overall revenue. Prominent
  players operating in the global electronic drug
  delivery systems market have been studied in
  detail.
• Rapidly increasing target diseases such as
  diabetes, cardiovascular diseases, asthma,
  chronic obstructive pulmonary disorder, multiple
  sclerosis is likely to fuel the demand for
  electronic drug delivery systems in the coming
  few years. Increase in geriatric patient pool
  susceptible to cardiovascular and respiratory
  disorders along with rapid technological
  advancements such as launch of integrated
  technologies is expected for robust market
  expansion in the coming few years. Moreover,
  favorable reimbursement scenario in developed
  regions is anticipated to fuel the growth of the
  market in the future.

3
Global Electronic Drug Delivery Systems Market Is
Expected To Witness An Lucrative Growth With A
CAGR Of 7.9 Over The Forecast Period

• North America dominated the global electronic
  drug delivery systems market in 2018. High
  prevalence of target diseases including diabetes
  and cardiovascular diseases, greater adoption of
  advanced drug delivery systems, increase in
  expenditure on diabetes care, presence of large
  geriatric population and favorable reimbursement
  scenario in the region are key factors likely to
  drive the growth of the market in the next few
  years. According to International Diabetes
  Federation (IDF), a total of 301,700 deaths were
  attributable to diabetes in 2019. Also,
  approximately, 325 billion was spent on diabetes
  in North America. However, Asia Pacific
  electronic drug delivery systems market is
  anticipated to grow at a rapid pace over the
  forecast period.
• Major players operating in the global electronic
  drug delivery systems market include Insulet
  Corporation, Medtronic plc, Merck Group, United
  Therapeutics Corporation, Novo Nordisk, Bayer AG,
  AstraZeneca, Amgen, Tandem Diabetes Care, and
  Phillips-Medisize among others.
• Browse the complete report on _at_
  https//www.adroitmarketresearch.com/industry-repo
  rts/electronic-drug-delivery-systems-market

4
Segment Overview of Global Electronic Drug
Delivery Systems Market

• Product Type Overview, 2015-2025 (USD Million)
• Electronic Wearable Infusion Pumps
• Electronic Autoinjectors
• Electronic Injection Pens
• Electronic Inhalers
• Application Overview, 2015-2025 (USD Million)
• Cardiovascular Diseases
• Asthma COPD
• Diabetes
• Multiple Sclerosis
• Others

5
Segment Overview of Global Electronic Drug
Delivery Systems Market

• Regional Overview, 2015-2025 (USD Million)
• North America
• Europe
• Asia Pacific
• South America
• Middle East Africa
• Purchase a single user copy of the global
  Electronic Drug Delivery Systems Market report_at_
  https//www.adroitmarketresearch.com/researchrepor
  t/purchase/1490

6
About Us

• Adroit Market Research is an India-based business
  analytics and consulting company. Our target
  audience is a wide range of corporations,
  manufacturing companies, product/technology
  development institutions and industry
  associations that require understanding of a
  markets size, key trends, participants and
  future outlook of an industry. We intend to
  become our clients knowledge partner and provide
  them with valuable market insights to help create
  opportunities that increase their revenues. We
  follow a code Explore, Learn and Transform. At
  our core, we are curious people who love to
  identify and understand industry patterns, create
  an insightful study around our findings and churn
  out money-making roadmaps. Our analysts have
  tracked high growth markets in chemicals
  materials, healthcare pharmaceuticals,
  semiconductor electronics, energy power, food
  retail, consumer goods, technology, and
  machinery equipment sectors across the world to
  identify new opportunities, potential customers,
  prepare go-to-market (GTM) strategies, identify
  segments for revenue growth for companies, and
  many more.

• US Headquarters3131 McKinney Ave Ste 600
  Dallas, TX 75204 ,U.S.A 

• Phone [phone]
• Email sales_at_adroitmarketresearch.com